Finance

Beta
Lists
GMRS:NYSE
GMR Solutions Inc
$14.68
-4.98%
(-0.77) 1D
Jul 1, 2:40:58 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GMRS...
Open
$15.38
High
$15.48
Low
$14.64
Mkt. cap
792.89M
Avg. vol.
1.02M
Volume
213.03K
P/E ratio
15.88
52-wk high
$15.54
52-wk low
$10.26
EPS
$0.92
No. of employees
34K
Open
$15.38
High
$15.48
Low
$14.64
Mkt. cap
792.89M
Avg. vol.
1.02M
Volume
213.03K
P/E ratio
15.88
52-wk high
$15.54
52-wk low
$10.26
EPS
$0.92
No. of employees
34K
News stories
From sources across the web
About GMR Solutions Inc
CEO-
Employees34K
Founded2015
Headquarters-
SectorHealth care provider
Websiteglobalmedicalresponse.com
Analyst ratings
Based on 8 analysts giving stock ratings to GMRS in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for GMRS in the last 3 months.
Highest
Current $14.68
$35.00 (+138.42%)
Average
$19.38 (+32.02%)
Lowest
$14.00 (-4.63%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Mok CFA
Barclays
Buy
Initiated
$16.00
+9%
06/08/2026
Joanna Gajuk
Bank of America Securities
Buy
Initiated
$18.00
+22.6%
06/08/2026
Craig Hettenbach
Morgan Stanley
Hold
Initiated
$14.00
-4.6%
06/09/2026
A.J. Rice
UBS
Buy
Initiated
$20.00
+36.2%
06/08/2026
James Kurek‏
UBS
Buy
Initiated
$20.00
+36.2%
06/08/2026
Benjamin Rossi
J.P. Morgan
Buy
Initiated
$15.00
+2.2%
06/08/2026
Daniel Grosslight
Citi
Buy
Initiated
$17.00
+15.8%
06/08/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Initiated
$20.00
+36.2%
06/07/2026
Scott Fidel
Goldman Sachs
Buy
Initiated
$35.00
+138.4%
06/07/2026
Last report
Jun 2, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
- / -
Revenue / Est. (USD)
1.46B / -
0.00%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
1.37B
1.46B
Cost of goods sold
846.57M
888.63M
Cost of revenue
846.57M
888.63M
Research and development expenses
-
-
Total research and development expenses
-
-
Selling, general, and admin expenses
33.65M
42.98M
Operating expense
320.03M
339.53M
Total operating expenses
1.17B
1.23B
Operating income
200.81M
229.42M
Other non operating income
922.00K
-556.00K
EBT including unusual items
67.39M
142.53M
EBT excluding unusual items
90.35M
146.15M
Income tax expense
29.37M
36.20M
Effective tax rate
43.58%
25.39%
Other operating expenses
211.25M
221.18M
Net income
38.02M
106.34M
Net profit margin
2.78%
7.30%
Earnings per share
-
-
Interest and investment income
-
-
Interest expense
-113.68M
-83.17M
Net interest expenses
-113.68M
-83.17M
Depreciation and amortization charges
75.13M
75.37M
EBITDA
275.93M
300.69M
Gain or loss from assets sale
16.78M
1.08M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer